Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2070 of 6351
-
Which tendon best fixes a slipping kneecap? a surgical showdown
Disease control CompletedThis prospective comparative study compared the clinical and radiological outcomes of medial patellofemoral ligament (MPFL) reconstruction using a hamstring tendon graft versus a quadriceps tendon graft in patients with recurrent patellar dislocation. The study included 38 patien…
Sponsor: Cairo University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Nerve repair breakthrough? tesamorelin trial aims to boost hand recovery
Disease control Recruiting nowThe aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Fasenra proven safe for Long-Term asthma control in Real-World study
Disease control CompletedThe purpose of the investigation is to confirm the safety and efficacy under the post-marketing actual long-term use of FASENRA Subcutaneous Injection 30 mg Syringe.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 26, 2026 12:33 UTC
-
Triple-Drug immunotherapy cocktail shows promise in advanced tumors
Disease control CompletedThe purpose of this study is to demonstrate the safety and preliminary activity with triple combinations of relatlimab in combination with nivolumab and BMS-986205, or in combination with nivolumab and ipilimumab in immunotherapy-naive and pretreated populations across select adv…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Double immune attack: new combo therapy targets Hard-to-Treat cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of pembrolizumab and recombinant interleukin-12 in treating patients with solid tumors. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfer…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Zapping tumors with electricity: a new hope for pancreatic cancer?
Disease control Recruiting nowCompare the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitabine in patients with locally advanced pancreatic cancer.
Phase 1 • Sponsor: University of Louisville • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New antibody combo aims to fight back against recurrent ovarian cancer
Disease control Recruiting nowThe main purpose of this study is to: * Learn about the safety of ubamatamab and to find out what dose of ubamatamab can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus * The study will also look at the levels of ubamatamab and/or cemipl…
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Cholesterol drug may calm inflammation after heart attack
Disease control CompletedVascular and myocardial inflammation are significantly increased in Acute Coronary Syndrome (ACS) patients, are closely correlated to LDL-C levels, and are associated with these adverse consequences in the post-ACS patient population. Serum proprotein convertase subtilisin/kerin …
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Heart CT scans may spot clots missed by standard tests
Diagnosis CompletedThe aim of the AIS of HEARTS registry is to establish a database to collect, maintain and provide accessible individual patient data from international cohorts and to provide pooled analyses about the yield and value of cardiac computed tomography (CT), acquired during the initia…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Your words could reveal your risk: AI analyzes speech to predict psychosis
Knowledge-focused Recruiting nowSubtle speech disorganization could be predictive of a transition to schizophrenia of ultra-high-risk patients. The aim of our longitudinal multicenter cohort study is to identify specific linguistic markers of the psychotic transition to validate a french predictive model of thi…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Lung cancer drug combo trial halted midway – what we know
Disease control Stopped earlyThis is a phase 3, open-label, 4-cohort study (3 randomized cohorts and 1 single-arm cohort). Participants enrolled in each cohort will be treated as detailed below. Each study cohort will be analyzed separately. Treatment will continue for up to 2 years, or until the patient exp…
Phase 3 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo aims to prevent deadly bowel blockages in ovarian cancer
Disease control CompletedOvarian cancer can often grow and cause obstructions in the bowel. These obstructions usually cannot be removed with surgery and can be fatal. This trial is testing whether a drug called cediranib can be used safely together with paclitaxel chemotherapy to treat ovarian cancer in…
Phase 2 • Sponsor: Prof Gordon Jayson • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple test spot pancreatic cancer before it starts?
Diagnosis Recruiting nowResearchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to save rectums in early cancer patients
Disease control OngoingThis is a single arm phase II study of neoadjuvant chemotherapy followed by local excision and post-operative chemoradiotherapy in patients with early stage, low rectal adenocarcinoma. After completion of pre-treatment tests/procedures (including pelvic MRI/ERUS; MRI is mandatory…
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New inhaled therapy for cystic fibrosis shows early promise
Disease control CompletedThis Phase 1/2, first-in-human study evaluated the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with cystic fibrosis (CF).
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a simple ultrasound replace CT scans for injured kids?
Diagnosis OngoingThe purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this study is to determine the sensitivity and specificity of contrast-enhanced ultraso…
Phase 4 • Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Cash for kids: can $333 a month boost a baby's brain?
Knowledge-focused OngoingRecent advances in developmental neuroscience suggest that experiences early in life can have profound and enduring influences on the developing brain. Family economic resources shape the nature of many of these experiences, yet the extent to which they affect children's developm…
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Could a natural compound help prevent cancer in a rare disease?
Prevention CompletedFanconi anemia (FA) is an autosomal recessive disease characterized by progressive bone marrow failure, variable congenital abnormalities and a predisposition to malignancy, particularly acute myeloid leukemia (AML) and squamous cell carcinoma (SCC). Improved transplant outcomes …
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Blood test could revolutionize sarcoma monitoring
Knowledge-focused OngoingThis is a prospective multicenter biomarker study evaluating the prognostic impact of ctDNA detection at diagnosis in patients with Ewing sarcoma or osteosarcoma.
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New cocktail therapy hopes to tackle tough lung cancer
Disease control OngoingThe objective of this study is to investigate the safety, tolerability, and antitumor activity of novel combination therapies administered in participants with advanced EGFRm NSCLC.
Phase 1/2 • Sponsor: MedImmune LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC